| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2009 | CN101410402A Buprenorphine derivatives and uses thereof |
| 04/15/2009 | CN101410400A Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/15/2009 | CN101410397A Organic compounds |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410393A Novel heteroaryl substituted benzothiazoles |
| 04/15/2009 | CN101410392A Amide substituted quinolines |
| 04/15/2009 | CN101410391A 2, 3-phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410389A Organic compounds |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410387A Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410384A Compounds and methods for modulating protein trafficking |
| 04/15/2009 | CN101410381A Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
| 04/15/2009 | CN101410378A Malonamide derivatives as gamma secretase inhibitors |
| 04/15/2009 | CN101410376A Piperazinyl derivatives as modulators of chemokine receptor activity |
| 04/15/2009 | CN101410372A Novel lactams |
| 04/15/2009 | CN101410371A Process for production of carotenoid |
| 04/15/2009 | CN101410370A Selective hydroxamate based MMP inhibitors |
| 04/15/2009 | CN101410369A Process for the preparation of tamsulosin and related compounds |
| 04/15/2009 | CN101410368A Viral polymerase inhibitors |
| 04/15/2009 | CN101410367A Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 04/15/2009 | CN101410366A Substituted bicyclic derivatives and use thereof |
| 04/15/2009 | CN101410139A Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 04/15/2009 | CN101410135A Immunogenic composition |
| 04/15/2009 | CN101410129A Extracts and methods comprising ganoderma species |
| 04/15/2009 | CN101410123A Formulations of low dose diclofenac and beta-cyclodextrin |
| 04/15/2009 | CN101410122A Method and composition for treating anaphylactic disease |
| 04/15/2009 | CN101410121A Dietary supplements containing probiotics |
| 04/15/2009 | CN101410120A 抗炎的膦酸酯化合物 Phosphonate compound anti-inflammatory |
| 04/15/2009 | CN101410119A Novel epoprostenol formulation and method of making thereof |
| 04/15/2009 | CN101410118A Treatment of pain |
| 04/15/2009 | CN101410117A New therapeutic comibinations for the treatment or prevention of psychotic disorders |
| 04/15/2009 | CN101410116A Urotensin II receptor antagonists |
| 04/15/2009 | CN101410115A Compositions containing riboflavin and sesamin-class compounds |
| 04/15/2009 | CN101410114A A3 adenosine receptor allosteric modulators |
| 04/15/2009 | CN101410113A Methods for treating cognitive and other disorders |
| 04/15/2009 | CN101410112A New therapeutic combinations for the treatment of depression |
| 04/15/2009 | CN101410111A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 04/15/2009 | CN101410110A Varenicline standards and impurity controls |
| 04/15/2009 | CN101410109A Antibiotic compositions of modified release and process of production thereof |
| 04/15/2009 | CN101410108A Use of a kinase inhibitor for the treatment of particular resistant tumors |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101410106A Method for treating nervous system disorders and conditions |
| 04/15/2009 | CN101410105A Combination treatment of metabolic disorders |
| 04/15/2009 | CN101410104A Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| 04/15/2009 | CN101410103A 固体药物制剂 The solid pharmaceutical preparation |
| 04/15/2009 | CN101410102A Compositions and methods for enhancing the antioxidant status of animals |
| 04/15/2009 | CN101410101A Anti-fat-accumulation composition |
| 04/15/2009 | CN101410100A Method and composition for treating acne using lignan compounds |
| 04/15/2009 | CN101410099A Polylactide nanoparticles |
| 04/15/2009 | CN101410098A Microspheres comprising nanocapsules containing a lipophilicdrug |
| 04/15/2009 | CN101410097A Soft-gelatin capsule formulation |
| 04/15/2009 | CN101410092A Mucosal bioadhesive slow release carrier for delivering active principles |
| 04/15/2009 | CN101410091A Drug delivery system for sustained delivery of glipizide |
| 04/15/2009 | CN101410090A Biguanide-containing liposomes |
| 04/15/2009 | CN101410012A Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin |
| 04/15/2009 | CN101407810A Small interfering RNA with midkine gene as target, vector and use thereof |
| 04/15/2009 | CN101407558A Preparation of Dendrobium nobile polysaccharide extract and use there |
| 04/15/2009 | CN101407557A Preparation and use of Dendrobium nobile polysaccharide extract |
| 04/15/2009 | CN101407556A Preparation of Cordyceps sinensis polysaccharide injection and use in cancer treatment |
| 04/15/2009 | CN101407534A 2'-fluoro-4'-substituted-nucleoside analogue and use thereof |
| 04/15/2009 | CN101407531A Use of dimer hydrolysable tannins derivative in preparing medicament and diet additive for treating obesity |
| 04/15/2009 | CN101407525A Cephalosporin derivatives |
| 04/15/2009 | CN101407524A Oxazino camptothecin derivative, preparation and use thereof |
| 04/15/2009 | CN101407523A Myrothecium mycelium extract for inhibiting growth of tumour cell |
| 04/15/2009 | CN101407520A Novel medical uses of aporphine alkaloid and derivative thereof |
| 04/15/2009 | CN101407517A Preparation of ambroxol theophylline-7-acetate |
| 04/15/2009 | CN101407516A Camptothecine derivative having anticancer activity |
| 04/15/2009 | CN101407515A Chinoline polycyclic compounds as CDK inhibitors |
| 04/15/2009 | CN101407514A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 04/15/2009 | CN101407511A Crystal type glyoxaline-5-carboxyl acid derivative |
| 04/15/2009 | CN101407506A Benzofuran derivatives and uses thereof |
| 04/15/2009 | CN101407505A Antivirus andrographolide derivative and preparation thereof |
| 04/15/2009 | CN101407502A N-(t-butoxy carbonyl ) timonacic compounds, and preparation and use thereof |
| 04/15/2009 | CN101407500A 3,4-diaryl isoxazole-5-amido derivative, and preparation and use thereof |
| 04/15/2009 | CN101407499A Triazine compounds having coccidiostat activity and preparation thereof |
| 04/15/2009 | CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407476A M-bis(arene) polysubstituted amino benzene compound as non-nucleoside HIV reverse transcriptase inhibitor, and preparation and use thereof |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101407467A N-substituted arene aniline / polysubstituted diaryl ether compound, preparation and anti-tumor use thereof |
| 04/15/2009 | CN101407460A Trihydroxy-2-acyl phenylacetate, and preparation and use thereof |
| 04/15/2009 | CN101407459A Monohydroxy-2-acyl phenylacetate, and preparation and use thereof |
| 04/15/2009 | CN101407457A Carboxyl substituted chalcone derivative, preparation and use |
| 04/15/2009 | CN101407456A Effective ingredient having beta-secretase inhibition effect in Homalonema occulta |
| 04/15/2009 | CN101406703A Transdermal analgesic systems with reduced abuse potential |
| 04/15/2009 | CN101406694A Formulation for increasing bone density and preparation thereof |
| 04/15/2009 | CN101406689A Method for producing liver-boosting capsule containing glutathione and other nine ingredients |
| 04/15/2009 | CN101406682A Method for producing plaster for dispelling children's tetanus neonatorium in six hours |
| 04/15/2009 | CN101406680A Compound syrup paste for epilepsy |
| 04/15/2009 | CN101406674A Quality control method of Ninggong tablet containing bezoar |
| 04/15/2009 | CN101406663A Medicine for treating cancer and method for producing the same |
| 04/15/2009 | CN101406661A Compound medicament for treating bacterial enteritis of aquatic livestock |
| 04/15/2009 | CN101406660A Medicament for improving organism immunity of aquatic livestock |
| 04/15/2009 | CN101406659A Health-care plaster for breast |
| 04/15/2009 | CN101406649A Total alkaloid extract, and extraction method thereof and use in preparing medicament for treating cough |
| 04/15/2009 | CN101406645A Chinese medicinal composition for hyperosteogeny |
| 04/15/2009 | CN101406641A Compound medicament for treating vitiligo |
| 04/15/2009 | CN101406630A Medicament for treating coronary heart disease |